ZA932440B - Indole derivatives - Google Patents
Indole derivativesInfo
- Publication number
- ZA932440B ZA932440B ZA932440A ZA932440A ZA932440B ZA 932440 B ZA932440 B ZA 932440B ZA 932440 A ZA932440 A ZA 932440A ZA 932440 A ZA932440 A ZA 932440A ZA 932440 B ZA932440 B ZA 932440B
- Authority
- ZA
- South Africa
- Prior art keywords
- indole derivatives
- indole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86473792A | 1992-04-07 | 1992-04-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA932440B true ZA932440B (en) | 1994-10-05 |
Family
ID=25343950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA932440A ZA932440B (en) | 1992-04-07 | 1993-04-05 | Indole derivatives |
Country Status (26)
| Country | Link |
|---|---|
| US (7) | US5747501A (cs) |
| EP (1) | EP0635017A1 (cs) |
| JP (1) | JP2644088B2 (cs) |
| KR (1) | KR0179072B1 (cs) |
| CN (2) | CN1050841C (cs) |
| AU (1) | AU670579B2 (cs) |
| BR (1) | BR9306201A (cs) |
| CA (1) | CA2133413C (cs) |
| CZ (1) | CZ281763B6 (cs) |
| EG (1) | EG20226A (cs) |
| FI (1) | FI931558A7 (cs) |
| HR (1) | HRP930752A2 (cs) |
| HU (1) | HUT64062A (cs) |
| IL (1) | IL105206A (cs) |
| MX (1) | MX9302011A (cs) |
| MY (1) | MY108909A (cs) |
| NO (1) | NO303388B1 (cs) |
| NZ (1) | NZ251086A (cs) |
| PL (1) | PL172405B1 (cs) |
| RU (1) | RU2101283C1 (cs) |
| SK (1) | SK280193B6 (cs) |
| TW (1) | TW341565B (cs) |
| UA (1) | UA27467C2 (cs) |
| WO (1) | WO1993020073A1 (cs) |
| YU (1) | YU48931B (cs) |
| ZA (1) | ZA932440B (cs) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5559129A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc | Indole derivatives |
| US5559246A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc. | Indole derivatives |
| US5578612A (en) * | 1990-10-15 | 1996-11-26 | Pfizer Inc. | Indole derivatives |
| US5545644A (en) * | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
| US5607951A (en) * | 1990-10-15 | 1997-03-04 | Pfizer Inc | Indole derivatives |
| EP0635017A1 (en) * | 1992-04-07 | 1995-01-25 | Pfizer Inc. | Indole derivatives as 5-ht1 agonists |
| ES2070087B1 (es) * | 1993-08-13 | 1996-02-16 | Pfizer | Derivados de indol |
| CN1129933A (zh) * | 1993-08-31 | 1996-08-28 | 辉瑞大药厂 | 5-芳基吲哚衍生物 |
| JPH10501212A (ja) * | 1994-05-19 | 1998-02-03 | メルク シヤープ エンド ドーム リミテツド | ５−ｈｔ▲下１ｄ▼−アルファ作働薬としてのインドール−３−イルアルキルのピペラジン、ピペリジンおよびテトラヒドロピリジン誘導体 |
| GB9415575D0 (en) * | 1994-08-02 | 1994-09-21 | Merck Sharp & Dohme | Therapeutic agents |
| GB9417310D0 (en) * | 1994-08-27 | 1994-10-19 | Pfizer Ltd | Therapeutic agents |
| GB9420529D0 (en) | 1994-10-12 | 1994-11-30 | Pfizer Ltd | Indoles |
| GB9423682D0 (en) * | 1994-11-23 | 1995-01-11 | Merck Sharp & Dohme | Therapeutic agents |
| AU699281B2 (en) * | 1994-12-06 | 1998-11-26 | Merck Sharp & Dohme Limited | Azetidine, pyrrolidine and piperidine derivatives as 5HT1 receptor agonists |
| ATE236154T1 (de) * | 1995-07-31 | 2003-04-15 | Shionogi & Co | Pyrrolydin-derivate mit einer phospholipase a2 inhibierenden wirkung |
| GB9519558D0 (en) * | 1995-09-26 | 1995-11-29 | Merck Sharp & Dohme | Therapeutic agents |
| US6051593A (en) * | 1997-06-20 | 2000-04-18 | Sugen, Inc. | 3-(cycloalkanoheteroarylidenyl)-2- indolinone protein tyrosine kinase inhibitors |
| JP2002519321A (ja) * | 1998-06-30 | 2002-07-02 | イーライ・リリー・アンド・カンパニー | セロトニン関連系に効果を有するピロリジン、及び、ピロリン誘導体 |
| WO2000008018A1 (fr) * | 1998-08-07 | 2000-02-17 | Takeda Chemical Industries, Ltd. | Derives de benzothiepine, leur procede de preparation et leurs utilisations |
| US5994352A (en) * | 1998-11-13 | 1999-11-30 | Pfizer Inc. | 5-arylindole derivatives |
| US6326388B1 (en) * | 1999-12-21 | 2001-12-04 | Celgene Corporation | Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level |
| ATE335477T1 (de) * | 2001-12-20 | 2006-09-15 | Wyeth Corp | Indolylalkylamin-derivate als 5-hydroxytryptamin- 6 liganden |
| RU2218189C1 (ru) * | 2002-05-28 | 2003-12-10 | Нижегородская государственная медицинская академия | Способ лечения мигрени в межприступном периоде заболевания |
| US7041697B2 (en) * | 2002-09-12 | 2006-05-09 | Wyeth | Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan |
| JP5199121B2 (ja) * | 2005-12-30 | 2013-05-15 | メルク・シャープ・エンド・ドーム・コーポレイション | Ｃｅｔｐ阻害剤 |
| EP2346505B1 (en) * | 2008-10-16 | 2014-04-23 | Janssen Pharmaceuticals, Inc. | Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
| US20100217013A1 (en) * | 2008-12-15 | 2010-08-26 | Wenge Li | Enantioselective process for the preparation of zolmitriptan |
| US20140206667A1 (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
| BR112018071617A2 (pt) | 2016-04-28 | 2019-02-19 | Jiangsu Hengrui Medicine Co., Ltd. | método para preparar inibidor de tirosina quinase e derivado do mesmo |
| AU2021215709A1 (en) * | 2020-02-04 | 2022-09-01 | Mindset Pharma Inc. | 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders |
| WO2025104491A1 (en) * | 2023-11-14 | 2025-05-22 | Mindset Pharma Inc. | Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA795239B (en) * | 1978-10-12 | 1980-11-26 | Glaxo Group Ltd | Heterocyclic compounds |
| ZA815541B (en) * | 1980-08-12 | 1983-03-30 | Glaxo Group Ltd | Heterocyclic compounds |
| US4689336A (en) * | 1981-01-02 | 1987-08-25 | Pfizer Inc. | Hypoglycemic 5-substituted oxazolidine 2,4-diones |
| GB8600397D0 (en) * | 1986-01-08 | 1986-02-12 | Glaxo Group Ltd | Chemical compounds |
| FR2601008B1 (fr) * | 1986-07-03 | 1990-03-30 | Sanofi Sa | Procede de synthese stereospecifique de derives de l'indole |
| US4968707A (en) * | 1987-06-10 | 1990-11-06 | Pfizer Inc. | Oxazolidin-2-one derivatives as hypoglycemic agents |
| GB8719167D0 (en) * | 1987-08-13 | 1987-09-23 | Glaxo Group Ltd | Chemical compounds |
| GB8724912D0 (en) * | 1987-10-23 | 1987-11-25 | Wellcome Found | Indole derivatives |
| GB8819024D0 (en) * | 1988-08-10 | 1988-09-14 | Glaxo Group Ltd | Chemical compounds |
| IL96891A0 (en) * | 1990-01-17 | 1992-03-29 | Merck Sharp & Dohme | Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them |
| ES2104708T3 (es) * | 1990-06-07 | 1997-10-16 | Zeneca Ltd | Compuestos heterociclicos terapeuticos. |
| US5545644A (en) | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
| US5578612A (en) | 1990-10-15 | 1996-11-26 | Pfizer Inc. | Indole derivatives |
| US5607951A (en) | 1990-10-15 | 1997-03-04 | Pfizer Inc | Indole derivatives |
| US5559246A (en) | 1990-10-15 | 1996-09-24 | Pfizer Inc. | Indole derivatives |
| DE10299004I2 (de) * | 1990-10-15 | 2006-03-16 | Pfizer | Indolderivate |
| US5559129A (en) | 1990-10-15 | 1996-09-24 | Pfizer Inc | Indole derivatives |
| US5208248A (en) * | 1991-01-11 | 1993-05-04 | Merck Sharpe & Dohme, Ltd. | Indazole-substituted five-membered heteroaromatic compounds |
| SK278998B6 (sk) * | 1991-02-01 | 1998-05-06 | Merck Sharp & Dohme Limited | Deriváty imidazolu, triazolu a tetrazolu, spôsob i |
| TW263508B (cs) * | 1991-02-12 | 1995-11-21 | Pfizer | |
| ATE190608T1 (de) | 1991-11-25 | 2000-04-15 | Pfizer | 5-(hetero- oder carbocyclylamino)-indol derivate, deren herstellung und deren verwendung als 5-ht1 agonisten |
| CA2083891A1 (en) * | 1991-12-03 | 1993-06-04 | Angus Murray Macleod | Heterocyclic compounds, compositions containing them and their use in therapy |
| US5409941A (en) | 1992-02-03 | 1995-04-25 | Pfizer Inc. | 5-heteroyl indole derivatives |
| TW288010B (cs) | 1992-03-05 | 1996-10-11 | Pfizer | |
| EP0635017A1 (en) * | 1992-04-07 | 1995-01-25 | Pfizer Inc. | Indole derivatives as 5-ht1 agonists |
| JP2544704B2 (ja) | 1992-04-10 | 1996-10-16 | フアイザー・インコーポレイテツド | ５−ｈｔ▲下１▼アゴニストとしてのアシルアミノインド―ル誘導体 |
| JP7121942B2 (ja) | 2018-04-10 | 2022-08-19 | アサヒビール株式会社 | 発泡性飲料移充填方法 |
| JP7121943B2 (ja) | 2018-04-27 | 2022-08-19 | 日本ゼオン株式会社 | レジストパターン形成方法 |
-
1993
- 1993-03-10 EP EP93907216A patent/EP0635017A1/en not_active Ceased
- 1993-03-10 KR KR1019940703552A patent/KR0179072B1/ko not_active Expired - Fee Related
- 1993-03-10 AU AU37898/93A patent/AU670579B2/en not_active Ceased
- 1993-03-10 CA CA002133413A patent/CA2133413C/en not_active Expired - Fee Related
- 1993-03-10 RU RU94045897/04A patent/RU2101283C1/ru not_active IP Right Cessation
- 1993-03-10 PL PL93305555A patent/PL172405B1/pl not_active IP Right Cessation
- 1993-03-10 NZ NZ251086A patent/NZ251086A/en unknown
- 1993-03-10 BR BR9306201A patent/BR9306201A/pt not_active Application Discontinuation
- 1993-03-10 UA UA94105899A patent/UA27467C2/uk unknown
- 1993-03-10 CZ CZ942464A patent/CZ281763B6/cs not_active IP Right Cessation
- 1993-03-10 JP JP5517443A patent/JP2644088B2/ja not_active Expired - Fee Related
- 1993-03-10 WO PCT/US1993/001967 patent/WO1993020073A1/en not_active Application Discontinuation
- 1993-03-10 US US08/295,798 patent/US5747501A/en not_active Expired - Fee Related
- 1993-03-10 SK SK1206-94A patent/SK280193B6/sk unknown
- 1993-03-29 IL IL10520693A patent/IL105206A/en not_active IP Right Cessation
- 1993-04-02 HR HR930752A patent/HRP930752A2/hr not_active Application Discontinuation
- 1993-04-05 MY MYPI93000616A patent/MY108909A/en unknown
- 1993-04-05 EG EG20593A patent/EG20226A/xx active
- 1993-04-05 ZA ZA932440A patent/ZA932440B/xx unknown
- 1993-04-06 CN CN93105697A patent/CN1050841C/zh not_active Expired - Fee Related
- 1993-04-06 YU YU23893A patent/YU48931B/sh unknown
- 1993-04-06 HU HU9301003A patent/HUT64062A/hu unknown
- 1993-04-06 MX MX9302011A patent/MX9302011A/es unknown
- 1993-04-06 FI FI931558A patent/FI931558A7/fi not_active IP Right Cessation
- 1993-04-09 TW TW082102651A patent/TW341565B/zh active
-
1994
- 1994-10-06 NO NO943762A patent/NO303388B1/no not_active IP Right Cessation
-
1998
- 1998-04-14 US US09/059,799 patent/US6150388A/en not_active Expired - Fee Related
- 1998-07-08 CN CN98116024A patent/CN1083443C/zh not_active Expired - Fee Related
-
2000
- 2000-10-23 US US09/694,808 patent/US6410739B1/en not_active Expired - Fee Related
- 2000-10-23 US US09/694,387 patent/US6436957B1/en not_active Expired - Fee Related
- 2000-10-23 US US09/694,809 patent/US6387941B1/en not_active Expired - Fee Related
- 2000-10-23 US US09/694,394 patent/US6387937B1/en not_active Expired - Fee Related
- 2000-10-23 US US09/694,588 patent/US6465500B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2266091B (en) | Indole derivatives | |
| ZA932440B (en) | Indole derivatives | |
| GB2251614B (en) | Indole derivatives | |
| ZA942383B (en) | New indole derivatives | |
| GB9208161D0 (en) | Indoles | |
| ZA941483B (en) | Indole derivatives | |
| AP9400685A0 (en) | Indole derivatives | |
| ZA947210B (en) | Indole derivatives | |
| GB9326332D0 (en) | Indole derivatives | |
| HU9201550D0 (en) | Indole derivatives | |
| AP9400633A0 (en) | Indole derivatives | |
| GB9116732D0 (en) | Indole derivatives | |
| GB9204024D0 (en) | Indole derivatives | |
| GB9310092D0 (en) | Indole derivatives | |
| GB9302577D0 (en) | Indole derivatives | |
| GB9206810D0 (en) | Indole derivatives | |
| GB9206056D0 (en) | Indole derivatives | |
| GB9206787D0 (en) | Indole derivatives | |
| GB9206794D0 (en) | Indole derivatives | |
| IL121326A0 (en) | Indole derivatives | |
| GB9218595D0 (en) | Indole derivatives | |
| GB9215961D0 (en) | Indole derivatives | |
| GB9206809D0 (en) | Indole derivatives | |
| GB9309148D0 (en) | Indole derivatives | |
| GB9307080D0 (en) | Indole derivatives |